The clinical value of high-density lipoprotein in the evaluation of new coronavirus pneumonia

BACKGROUND: The new coronavirus pneumonia (NCP, COVID-19) outbreak began in Wuhan December 2019. (2019 novel (2019-nCoV)) can cause multiple organ damage, mainly to lung tissue, and induce inflammation the body. OBJECTIVES: To investigate changes of high-density lipoprotein (HDL) level patients with COVID-19 assess its value evaluation prognosis this disease. MATERIAL AND METHODS: This paper is a cross-sectional retrospective study. Eighty-six severe patients, 132 non-severe 76 healthy individuals (control group) were recruited measure triglyceride (TG), total cholesterol (TC), (HDL-C), low-density (LDL-C) using enzyme-coupled colorimetry. RESULTS: serum HDL-C group was 1.02 ±0.28 mmol/L which significantly lower than control (1.52 ±0.55 mmol/L) (p < 0.05). In addition, 0.83 ±1.67 mmol/L, that (1.15 ±0.27 CONCLUSIONS: Changes HDL levels reflect severity disease have clinical significance establishing prognosis.